Enerzair Breezhaler 50 mcg (Glycopyrronium (Glycopyrronium Bromide) CAPSULE) 50 MCG

ENERZAIR BREEZHALER 50 MCG is a medication used for managing chronic obstructive pulmonary disease (COPD). This inhalation capsule contains glycopyrronium bromide, a bronchodilator that helps improve breathing. It is designed for easy use with the BREEZHALER device.

Strength

50 MCG

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ENERZAIR BREEZHALER 50 MCG is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This medication works by relaxing the muscles in the airways, which helps to open them up and make breathing easier. It is often prescribed for individuals who require long-term management of their COPD symptoms.

Side Effects

Common effects of ENERZAIR BREEZHALER 50 MCG may include dry mouth, throat irritation, and coughing. Some users might experience headaches or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

ENERZAIR BREEZHALER 50 MCG should be used as directed by a healthcare professional. It is important to follow the proper inhalation technique to ensure effective delivery of the medication. Patients with certain medical conditions, such as asthma or severe allergies, should discuss their health status with their doctor before using this medication.

Avoid Interactions

ENERZAIR BREEZHALER 50 MCG may interact with other medications, including beta-blockers and anticholinergics. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy of the medication.

Frequently Asked Questions

ENERZAIR BREEZHALER 50 MCG is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD).

ENERZAIR BREEZHALER 50 MCG is an inhalation capsule that should be used with the BREEZHALER device. Follow the instructions provided by your healthcare provider for proper use.

Common side effects may include dry mouth, throat irritation, and coughing. Some users might experience headaches or dizziness.

It is important to discuss alcohol consumption with your healthcare provider, as it may affect the efficacy of the medication.

Patients with certain medical conditions, such as asthma or severe allergies, should discuss their health status with their doctor before using this medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.